Formulation with CpG oligodeoxynucleotides increases cellular immunity and protection induced by vaccination of calves with formalin-inactivated bovine respiratory syncytial virus (Q45414761)

From Wikidata

Jump to navigation Jump to search

scientific article published on 7 July 2006

Language	Label	Description	Also known as
English	Formulation with CpG oligodeoxynucleotides increases cellular immunity and protection induced by vaccination of calves with formalin-inactivated bovine respiratory syncytial virus	scientific article published on 7 July 2006

Statements

scholarly article

1 reference

Europe PubMed Central

14 December 2017

Formulation with CpG oligodeoxynucleotides increases cellular immunity and protection induced by vaccination of calves with formalin-inactivated bovine respiratory syncytial virus (English)

1 reference

Europe PubMed Central

14 December 2017

5

object named as

Lorne A Babiuk

1 reference

Europe PubMed Central

14 December 2017

Sylvia van Drunen Littel-van den Hurk

6

object named as

Sylvia van Drunen Littel-van den Hurk

1 reference

Europe PubMed Central

14 December 2017

1

object named as

John W Mapletoft

1 reference

Europe PubMed Central

14 December 2017

Oumouna Mustapha

2

object named as

Mustapha Oumouna

1 reference

Europe PubMed Central

14 December 2017

4

object named as

Susantha Gomis

1 reference

Europe PubMed Central

14 December 2017

author name string

Hugh G Townsend

3

1 reference

Europe PubMed Central

14 December 2017

language of work or name

0 references

publication date

7 July 2006

1 reference

Europe PubMed Central

14 December 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

14 December 2017

353

1 reference

Europe PubMed Central

14 December 2017

2

1 reference

Europe PubMed Central

14 December 2017

316-323

1 reference

Europe PubMed Central

14 December 2017

Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.001

7 January 2021

CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.001

7 January 2021

Respiratory syncytial virus: reverse genetics and vaccine strategies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.001

7 January 2021

Influence of maternal antibodies on neonatal immunization against respiratory viruses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.001

7 January 2021

Type 1 and type 2 responses in regulation of Ig isotype expression in cattle

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.001

7 January 2021

Development of short non-CpG phosphodiester oligonucleotides as immune stimulatory agents.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.001

7 January 2021

Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.001

7 January 2021

Respiratory syncytial virus immunobiology and pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.001

7 January 2021

CpG containing oligodeoxynucleotides are potent adjuvants for parenteral vaccination with the fusion (F) protein of respiratory syncytial virus (RSV).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.001

7 January 2021

Mechanism and function of a newly identified CpG DNA motif in human primary B cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.001

7 January 2021

Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.001

7 January 2021

From the National Institute of Allergy and Infectious Diseases and the World Health Organization. Respiratory syncytial and parainfluenza viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.001

7 January 2021

CpG-containing oligodeoxynucleotides, in combination with conventional adjuvants, enhance the magnitude and change the bias of the immune responses to a herpesvirus glycoprotein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.001

7 January 2021

The immunogenicity and protective efficacy of bovine herpesvirus 1 glycoprotein D plus Emulsigen are increased by formulation with CpG oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.001

7 January 2021

Safety of CpG oligodeoxynucleotides in veterinary species

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.001

7 January 2021

Formalin-inactivated bovine RSV vaccine enhances a Th2 mediated immune response in infected cattle.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.001

7 January 2021

Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.001

7 January 2021

Priming for local and systemic antibody memory responses to bovine respiratory syncytial virus: effect of amount of virus, virus replication, route of administration and maternal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.001

7 January 2021

CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.001

7 January 2021

Gene gun-mediated DNA immunization primes development of mucosal immunity against bovine herpesvirus 1 in cattle

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.001

7 January 2021

Innate cellular immune responses in newborns

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.001

7 January 2021

Survival of group B streptococcus type III in mononuclear phagocytes: differential regulation of bacterial killing in cord macrophages by human recombinant gamma interferon and granulocyte-macrophage colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.001

7 January 2021

Hypomethylation of the interferon-gamma gene correlates with its expression by primary T-lineage cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.001

7 January 2021

Formulation with CpG oligodeoxynucleotides prevents induction of pulmonary immunopathology following priming with formalin-inactivated or commercial killed bovine respiratory syncytial virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.001

7 January 2021

Respiratory syncytial virus-induced chronic bronchiolitis in experimentally infected calves

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.001

7 January 2021

Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.001

7 January 2021

The in vivo effects of recombinant bovine herpesvirus-1 expressing bovine interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.001

7 January 2021

Best minimally modified antisense oligonucleotides according to cell nuclease activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.001

7 January 2021

Potential advantages and risks of nucleic acid vaccines for infant immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.001

7 January 2021

Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.001

7 January 2021

Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.001

7 January 2021

Respiratory syncytial virus. Brief review

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.001

7 January 2021

An experimental infection model for reproduction of calf pneumonia with bovine respiratory syncytial virus (BRSV) based on one combined exposure of calves.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.001

7 January 2021

Antibody dynamics in BRSV-infected Danish dairy herds as determined by isotype-specific immunoglobulins.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.001

7 January 2021

Immunization of neonates with DNA encoding a bovine herpesvirus glycoprotein is effective in the presence of maternal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.001

7 January 2021

Interferon gamma production during bovine respiratory syncytial virus (BRSV) infection is diminished in calves vaccinated with formalin-inactivated BRSV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.001

7 January 2021

Neonates mount robust and protective adult-like CD8(+)-T-cell responses to DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.001

7 January 2021

Identifiers

10.1016/J.VIROL.2006.06.001

1 reference

Europe PubMed Central

14 December 2017

1 reference

Europe PubMed Central

14 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45414761&oldid=2076860972"